The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
Trump's tweet comes a day after Apple put out a press release describing the money it spends on U.S.-based suppliers and vendors.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
President Donald Trump held a call on Wednesday with the CEOs of three major U.S. banks, according to people with knowledge of the situation.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Scientists say the smoke plumes, filled with megatons of tiny, harmful particles, could travel to other areas of the world and cause serious respiratory problems for people.Weather & Natural Disastersread more
Some Weight Watchers loyalists applaud Kurbo by WW. But nutritionists worry Kurbo promotes an unhealthy relationship with food during an especially impressionable time.Health and Scienceread more
Benefits from what President Trump called "the biggest reform of all time" to the tax code have dwindled to a faint breeze just 20 months after its enactment, writes John...Politicsread more
Epstein, 66, was found in his cell in Manhattan federal lockup Saturday morning and transferred to a nearby hospital, where he was subsequently pronounced dead.Politicsread more
Air travelers faced delays at U.S. airports on Friday afternoon after a computer issue snarled processing of international arrivals.Airlinesread more
Drug stocks fell suddenly on Thursday on the back of a report that President Donald Trump was ready to issue an executive order aimed at lowering drug prices.
The iShares Nasdaq Biotechnology ETF (IBB) hit session lows and traded 1.1 percent lower after Bloomberg reported, citing people familiar with the matter, that the administration could move on the matter within weeks.
The White House had no comment on the report.
Allergan CEO Brent Saunders said Thursday he has heard rumors about what Trump's executive order may include.
"One thing that we hear is on the table for an executive order is the directive for the Trump administration to move towards value-based contracting for pharmaceutical purchasing. I think that is a good, positive, constructive outcome for the industry and for patients," Saunders told CNBC's "Power Lunch."
Drug pricing has been a key issue for Trump as his administration tries to repeal and replace Obamacare. Earlier this year, the IBB tumbled after Trump teased in a tweet that drug prices would be coming "way down. "
IBB intraday chart
—CNBC's Eamon Javers contributed to this report.